Short- and Long-term Outcomes in Patients with Connective Tissue Diseases Undergoing Percutaneous Coronary

Li Zhou, Hui Chen, Wei-Ping Li

  • 1Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Insights

Coronary artery disease (CAD) in connective tissue diseases (CTDs) presents severe lesions and higher risks post-percutaneous coronary intervention (PCI). Patients with CTD undergoing PCI face increased stent thrombosis and target vessel revascularization rates.

Area of Science:

  • Cardiology
  • Rheumatology
  • Interventional Cardiology

Background:

  • Connective tissue diseases (CTDs) are associated with increased morbidity and mortality from coronary artery disease (CAD).
  • Risk factors and clinical profiles of CAD in CTD patients differ from the general population.
  • Understanding outcomes in CTD patients undergoing percutaneous coronary intervention (PCI) is crucial.

Purpose of the Study:

  • To evaluate short- and long-term clinical outcomes.
  • To analyze outcomes in patients with CTD undergoing PCI with stent implantation.

Main Methods:

  • Retrospective analysis of 106 consecutive CTD patients undergoing PCI (Jan 2009-June 2012).
  • Data collected included clinical characteristics, coronary angiogram findings, and major adverse cardiac events (MACEs).
  • Median follow-up duration was 3 years.

Main Results:

  • 86.8% of patients had traditional CAD risk factors; 73.6% had multivessel disease.
  • Long-term follow-up (36 months) showed a 12.3% cardiac death rate, 9.4% stent thrombosis, and 14.2% target vessel revascularization (TVR).
  • Hypertension, anterior myocardial infarction, prolonged steroid use, and elevated C-reactive protein were independent predictors of MACEs.

Conclusions:

  • CTD patients with CAD often present with severe coronary lesions.
  • PCI in CTD patients is associated with higher rates of stent thrombosis and TVR.
  • Both traditional and non-traditional risk factors influence outcomes in this population.
Abstract

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
638
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
687